(888) 391-1315


More than 16,000 women have already filed a Yaz lawsuit. Do you have a case?

SEE THE SIDE EFFECTSthe yaz litigation
Have you suffered from Yaz blood clot side effects?
free case review
yaz lawsuit settlements

Bayer: Yaz Lawsuit Settlements

More than 16,000 patients have filed a Yaz lawsuit so far for injuries based on the failure of Bayer to warn of the risks. Now, the company has started settling many cases with those who suffered blood clot-related injuries such as DVT, pulmonary embolism or stroke. 

Birth Control Lawsuits Over Blood Clots

Yaz and Yasmin became widely used after heavy marketing by Bayer showing them as birth control alternatives that promised safety with limited PMS, bloating, and acne, compared to traditional oral contraceptives. An estimated 100 million women have been prescribed the drugs.

Today, Yaz is still among the most widely used birth control drugs in the United States. In recent years, however, the FDA, Institute for Safe Medication Practices, British Medical Journal, New England Journal of Medicine and other experts have warned that Yaz and Yasmin may be linked to blood clots. 

Based on Bayer’s most recent financial records update, they have already spent around $1.75 billion to settle nearly 9,000 claims. More funds have been reserved for those affected, however, victims must still file a Yaz lawsuit to take part in the settlement, and time is limited.

If you suffered a blood clot, DVT, pulmonary embolism or stroke after taking Yaz, it is important to speak with a lawyer as soon as possible to find out how to be included in the current Yaz settlement. Contact us today to speak with a lawyer. 


  • What you need to know about the Yaz & Yasmin litigation.

  • Yaz & Yasmin FAQs from women experiencing side effects.

  • Here are the answers to our most common questions!

How do you qualify for a Yaz lawsuit?

Anyone who suffered a blood clot, deep vein thrombosis (DVT) or pulmonary embolism while taking Yaz or Yasmin  before 2013 may qualify for a case and should speak with a lawyer. DrugNews can connect you with a lawyer today.

Is there a Yaz class action lawsuit?

No. Yaz lawsuits are being filed and settled separately, instead of as a class action. However, these cases were consolidated to a federal MDL court in Illinois.

How much are Yaz cases worth?

Every case is unique and has its own value. However, the average amount awarded is around $200,000.

Why are women filing lawsuits against Bayer for Yaz and Yasmin?

The chemical drospirenone used in these drugs has been linked to an increased risk in blood clots that can cause deep vein thrombosis and pulmonary embolism. So far, more than 25,000 women have suffered serious blood clot side effects. Bayer has already paid out nearly $2 billion in settlements to those injured.

What is involved in filing a claim? How long will it take me?

It’s easy to file a claim. Yu can speak with a lawyer at no cost to see if you qualify, then they will gather your medical records to begin building a case. Once your case is proven, your lawyer will schedule it for trial or try to negotiate a settlement. This can take from 6 months to 2 years. However, it costs you nothing unless you receive compensation.

Assistance is available. Speak with a patient advocate today.

Multidistrict Litigation (MDL) Court in Illinois

Due to the number of patients filing a Yaz lawsuit, the cases were consolidated to a special federal Multi-District Litigation court in Illinois. This differs from a class action lawsuit in that claims are still handled individually, which can result in higher awards. Also, victims are free to choose their own legal counsel.

Bayer chose to settle the growing claims after a wave of repeated publications linking Yaz and Yasmin to blood clots.

In 2011, the British Medical Journal and FDA both warned that combined hormone drugs which contain drospirenone, such as Yaz and Yasmin, may substantially increase the risk of blood clots.

The Institute for Safe Medicine Practices reported in May of 2012 that Yaz and Yasmin ranked second highest in 2011 for the number of complications reported to the FDA. So far, the agency has received over 16,000 adverse reports related to Yaz or Yasmin just for DVT or pulmonary embolism.

Blood clots can cause serious or life-threatening conditions like stroke, deep vein thrombosis (DVT), or pulmonary embolism.

compensation to victims


follow us

Compensation for Victims of Side Effects

Those who have suffered lost wages, medical bills, hospitalization, ongoing treatment or pain and suffering from blood clots can get help with the proceeds of a Yaz lawsuit. Lawyers are still helping those affected file claims, however, recent news indicates the litigation could end this year.

If you have been treated for a blood clot injury such as DVT, pulmonary embolism or stroke after taking Yaz, it is important to find out whether you can be included in the settlement, how to proceed and how long you have to take action. 

Bayer has indicated they are only settling lawsuits involving blood clot injuries and only certain cases may qualify. A lawyer can discuss your situation today.

Due to the complex and specialized nature of federal defective drug litigation, it is important to find a lawyer or law firm with experience fighting large drug companies. 

The DrugNews Center only recommends lawyers who specialize in defective drug cases and have already settled numerous Yaz lawsuits. 

For more information on the side effects or legal action involving Yaz, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.

view sources

Graham, D. Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints. FDA. (October 27, 2011). Retrieved from

Nielsen, L. Risk of Venous Thromboembolism From Use of Oral Contraceptives Containing Different Progestogens and Oestrogen Doses: Danish Cohort Study, 2001-9. British Medical Journal. (October 25, 2011). Retrieved from

Brown, P. Yaz Lawsuit Settlement: Bayer to Pay $1 Billion Plus to Settle Yasmin Litigation. Newswire. (March 24, 2013). Retrieved from